Medtech companies raised more than $738 million in Q2

Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1.

Digital Surgery touts artificial intelligence for the operating room

Officials at Digital Surgery (London) boast that they have successfully demonstrated a real-time, dynamic artificial intelligence (AI) system designed for the operating room. The patented AI platform includes surgical procedure roadmaps that are meant to aid the surgical team in an OR. The goal is to reduce risk and make surgery safer. “This is a huge milestone for

Medtech stories we missed this week: July 13, 2018

From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Angiodroid wins CE Mark for Angiopulse IABP Angiodroid announced in a July 11 press releasethat it has received CE Mark approval for its AngioPulse intra-aortic balloon pump

Dune Medical debuts waste-saving surgical probe

Dune Medical Devices has designed a reposable version of its MarginProbe radiofrequency spectropscopy device, which can help surgeons identify remaining cancer cells in real time during a lumpectomy. The updated MarginProbe has a  reusable cable and handle and a single-use attachable probe. It has the potential to reduce waste burden of the MarginProbe up to

MedPlast completes Advanced Surgical and Orthopedics acquisition, rebrands as Viant

MedPlast announced that it has finished the acquisition of Integer Holding’s Advanced Surgical and Orthopedics business. The company plans to rebrand as Viant to showcase the new strategic direction. “Today marks an exciting day for our company. The addition of Integer’s business expands our capabilities and offerings and enables us to achieve our goal of

Medtech stories we missed this week: July 6, 2018

From Zetta getting FDA clearance to Prescient Medical receiving CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Zetta wins FDA clearance for Zoom MRI software Zetta announced in a June 25 press release that its MRI software has received FDA 510(k) clearance. The software, known as

Integer sells advanced surgical, ortho lines to MedPlast

Integer (NYSE:ITGR) has completed the spinoff of its advanced surgical and orthopedics products lines to MedPlast, LLC for $600 million in cash. Announced in May, the deal will double MedPlast’s top line and bolster the balance sheet for Integer, which missed expectations with its first-quarter earnings. MedPlast also announced that it will rebrand under the name

How’d they do that? 7 innovations from medical device contract manufacturers

Charles Darwin wrote, “In the long history of humankind (and animal kind, too) those who learned to collaborate and improvise most effectively have prevailed.” Medical device companies get the credit for many innovations, but many need the ingenuity and commitment of contract manufacturers who design and produce the components that make those big splashes possible.

Pages: 1 2 3 4 5 6 7 8

Study: No difference in complications, survival rate between robot-assisted and open bladder surgeries

A seven-year study comparing outcomes from robotic and open cystectomy procedures showed no statistically significant difference in complications or survival rate between the two methods. The randomized open versus robotic cystectomy study, known as the Razor trial, is touted as the first comprehensive study to compare outcomes between robotic and traditional open surgeries in any […]

Fortive offers $2.8B for J&J’s advanced sterilization biz

Johnson & Johnson (NYSE:JNJ) said yesterday that industrial conglomerate Fortive (NTSE:FTV) made a binding offer to acquire the advanced sterilization business from J&J’s Ethicon division for approximately $2.8 billion. The deal includes $2.7 billion in cash and an additional $100 million in retained net receivables, New Brunswick, N.J.-based Johnson & Johnson said. J&J’s advanced sterilization products biz […]

Olympus launches electrosurgical knife to shorten procedure times

Olympus recently announced that it has launched its DualKnife J endoscopic submucosal dissection (ESD) electrosurgical knife that uses submucosal injection to support safe and reliable ESD performance. “DualKnife J allows us to further innovative ESD procedures as part of an overall value-based care initiative, providing more minimally invasive procedures to patients so they may reap

Power morcellation: Questions linger for controversial tech

Dr. Amy Reed’s tragic case brought to light the cancer risks posed by power morcellation. Her death hasn’t stopped lingering questions about the technology. Power morcellators were used for 20 years to laparoscopically remove fibroids, benign tumors of the uterus, raising not a single adverse event report with the FDA. That all changed in 2013,

Medtech stories we missed this week: May 25, 2018

From Mauna Kea receiving FDA clearance to Medacta getting clearance for its pedicle screw placement guide, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Mauna Kea wins FDA nod for neurosurgery indication Mauna Kea announced in a May 24 press releasethat it has received FDA 510(k) clearance for

Medtech stories we missed this week: May 11, 2018

From ReShape submitting an approval application to Health Canada to Conavi receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. ReShape submits for Health Canada approval of ReShape balloon ReShape announced in a May 10 press releasethat it has submitted an application to the Medical Devices Bureau of

Alcon launches project to reduce cataract blindness

Alcon, a division of Novartis, launched its Alcon Cares Project 100 to take steps in reducing cataract blindness globally. The company also plans to donate 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America and Africa over the next three years. Alcon aims to reduce cataract blindness by providing equipment to